News

PMCPA News

Press releases appear below, filter by date.

Novo Nordisk Limited, Eli Lilly and Company Limited, Grunenthal Ltd and Napp Pharmaceuticals Limited named in advertisements for breaches of the ABPI Code of Practice

Novo Nordisk Limited, Eli Lilly and Company Limited, Grünenthal Ltd and Napp Pharmaceuticals Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry. 

Press release: 14 December 2010
ProStrakan Group plc, Cephalon UK Limited and GlaxoSmithKline Consumer Healthcare named in advertisements for breaches of the ABPI Code of Practice

ProStrakan Group plc, Cephalon UK Limited and GlaxoSmithKline Consumer Healthcare have each breached the ABPI Code of Practice for the Pharmaceutical Industry.
​To highlight these breaches, all are the subject of advertisements in the medical, pharmaceutical and nursing press.

Press release: 18 August 2010
Astellas Pharma named in advertisements for breaches of the ABPI Code of Practice

Astellas Pharma named in advertisements following breaches of the ABPI Code of Practice.

Press release: 01 July 2010
PMCPA publishes public consultation on proposed amendments to the ABPI Code of Practice for the Pharmaceutical Industry

The Prescription Medicines Code of Practice Authority (PMCPA) has now published its public consultation on proposed amendments to the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry.

Press release: 08 May 2010
Solvay Healthcare Limited, Pfizer Limited and Procter & Gamble Pharmaceuticals UK, Limited named in advertisements for breaches of the ABPI Code of Practice

Solvay Healthcare Limited, Pfizer Limited and Procter & Gamble Pharmaceuticals UK, Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry.
To highlight these breaches, all are the subjects of advertisements in the medical, pharmaceutical and nursing press. In addition Solvay has been publicly reprimanded.

Press release: 06 April 2010
About 161 result(s)